Circulating transforming growth factor-beta levels and myocardial remodeling in young adults with mitral valve prolapse patients

[1]  P. Gallo,et al.  Abnormal Papillary Muscle Signal on Cine MRI As a Typical Feature of Mitral Valve Prolapse , 2020, Scientific Reports.

[2]  R. Kim,et al.  Myocardial Fibrosis in Patients With Primary Mitral Regurgitation With and Without Prolapse. , 2018, Journal of the American College of Cardiology.

[3]  Allan Klein,et al.  A Test in Context: Myocardial Strain Measured by Speckle-Tracking Echocardiography. , 2017, Journal of the American College of Cardiology.

[4]  Francesca N. Delling,et al.  Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia , 2016, Heart.

[5]  F. Flachskampf,et al.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[6]  G. Gerosa,et al.  TGF-beta1 pathway activation and adherens junction molecular pattern in nonsyndromic mitral valve prolapse. , 2015, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[7]  V. Lesauskaitė,et al.  Blood Plasma TGF- β1 Concentration in Sporadic Dilatative Pathology of Ascending Aorta: More Questions than Answers , 2015, PloS one.

[8]  P. Robinson,et al.  Total Serum Transforming Growth Factor‐β1 Is Elevated in the Entire Spectrum of Genetic Aortic Syndromes , 2014, Clinical cardiology.

[9]  L. Vasina,et al.  Cardiomyopathy in young adults with classic mitral valve prolapse , 2013, Cardiology in the Young.

[10]  S. Wolff,et al.  Relation of mitral valve prolapse to basal left ventricular hypertrophy as determined by cardiac magnetic resonance imaging. , 2012, The American journal of cardiology.

[11]  V. Castronovo,et al.  Metallothionein-dependent up-regulation of TGF-β2 participates in the remodelling of the myxomatous mitral valve. , 2012, Cardiovascular research.

[12]  N. Keser,et al.  Classic Mitral Valve Prolapse Causes Enlargement in Left Ventricle Even in the Absence of Significant Mitral Regurgitation , 2012, Echocardiography.

[13]  David A. Bluemke,et al.  Cardiac remodeling at the population level—risk factors, screening, and outcomes , 2011, Nature Reviews Cardiology.

[14]  J. Camm,et al.  Impaired Biventricular Deformation in Marfan Syndrome: A Strain and Strain Rate Study in Adult Unoperated Patients , 2011, Echocardiography.

[15]  Victor Mor-Avi,et al.  Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. , 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[16]  Joyce Wong,et al.  Evidence for Marfan cardiomyopathy , 2010, European journal of heart failure.

[17]  A. Borg,et al.  Left ventricular filling and diastolic myocardial deformation in chronic primary mitral regurgitation. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[18]  J. Camm,et al.  Biventricular and atrial diastolic function assessment using conventional echocardiography and tissue-Doppler imaging in adults with Marfan syndrome. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[19]  H. Dietz,et al.  Circulating Transforming Growth Factor-&bgr; in Marfan Syndrome , 2009, Circulation.

[20]  G. Ávila,et al.  Role of TGF-β on cardiac structural and electrical remodeling , 2008, Vascular health and risk management.

[21]  M. Goumans,et al.  Transforming growth factor beta-induced endothelial-to-mesenchymal transition: a switch to cardiac fibrosis? , 2008, Trends in cardiovascular medicine.

[22]  Maja Cikes,et al.  Velocity and deformation imaging for the assessment of myocardial dysfunction. , 2008, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[23]  Gregory B. Sands,et al.  Three-dimensional transmural organization of perimysial collagen in the heart , 2008, American journal of physiology. Heart and circulatory physiology.

[24]  R. Sheppard,et al.  Fibrosis in heart disease: understanding the role of transforming growth factor‐β1 in cardiomyopathy, valvular disease and arrhythmia , 2006, Immunology.

[25]  S. Rosenkranz,et al.  Alterations of β-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-β1 , 2002 .

[26]  T. Doetschman,et al.  TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II , 2002 .

[27]  H. H. França,et al.  An interpretation--mitral valve prolapse syndrome. , 2000, Arquivos brasileiros de cardiologia.

[28]  J. Gardin,et al.  Anthropometric and physiologic correlates of mitral valve prolapse in a biethnic cohort of young adults: the CARDIA study. , 1999, American heart journal.

[29]  R A Levine,et al.  Prevalence and clinical outcome of mitral-valve prolapse. , 1999, The New England journal of medicine.

[30]  E. Malev,et al.  Evaluation of left ventricular systolic function in young adults with mitral valve prolapse. , 2012, Experimental and Clinical Cardiology.

[31]  T. Doetschman,et al.  TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. , 2002, The Journal of clinical investigation.

[32]  P. Howe,et al.  Analysis of TGFβ-Mediated Synthesis of Extracellular Matrix Components , 2000 .

[33]  P. Howe,et al.  Analysis of TGF-beta-mediated synthesis of extracellular matrix components. , 2000, Methods in molecular biology.